Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial. Turan TN, Voeks JH, Chimowitz MI, Roldan A, et al. Stroke 2020;51:2960-2971.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Turan TN, Voeks JH, Chimowitz MI, Roldan A, et al. Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial. Stroke 2020;51:2960-2971.
PMID: 32951538